Harvard Bioscience
HBIO
#8485
Rank
NZ$0.18 B
Marketcap
$4.35
Share price
-1.10%
Change (1 day)
-39.38%
Change (1 year)

Harvard Bioscience (HBIO) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$67 M

According to Harvard Bioscience's latest financial reports the company's total debt is NZ$67 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Harvard Bioscience - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$67.63 M-20.83%
2022-12-31NZ$85.43 M2.72%
2021-12-31NZ$83.17 M3.85%
2020-12-31NZ$80.08 M-16.2%
2019-12-31NZ$95.56 M5.49%
2018-12-31NZ$90.59 M447.66%
2017-12-31NZ$16.54 M-16.64%
2016-12-31NZ$19.84 M-27.58%
2015-12-31NZ$27.4 M0.21%
2014-12-31NZ$27.34 M-9.27%
2013-12-31NZ$30.13 M90.78%
2012-12-31NZ$15.79 M-24.37%
2011-12-31NZ$20.88 M-10.91%
2010-12-31NZ$23.44 M26.88%
2009-12-31NZ$18.47 M650.6%
2008-12-31NZ$2.46 M-75.45%
2007-12-31NZ$10.02 M135.44%
2006-12-31NZ$4.25 M-65.84%
2005-12-31NZ$12.46 M-46.22%
2004-12-31NZ$23.17 M14.28%
2003-12-31NZ$20.28 M865.89%
2002-12-31NZ$2.09 M-80.76%
2001-12-31NZ$10.91 M62007.49%
2000-12-31NZ$0.01 M-99.89%
1999-12-31NZ$15.43 M